#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital megacolon Myelodysplastic syndrome with excess blasts Myxofibrosarcoma Short stature Angiosarcoma Depression Factor IX deficiency Albright's disease Soft tissue sarcoma Lymphangioma Pemphigoid Nephroblastoma Chronic myelomonocytic leukaemia Marginal zone lymphoma refractory Immune thrombocytopenia More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Diagnostics Mucopolysaccharidosis II Tuberous sclerosis complex – Treatment Inclusion body myositis – Treatment Antithrombin III deficiency Optic glioma – Trials in Disease Hereditary ataxia – Diagnostics Usher’s syndrome Glycogen storage disease type II – Treatment Indolent systemic mastocytosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sonidegib Izaflortaucipir (18F) Regn5668 HSP-CAR19M Tub-040 Lenacapavir Sodium Taldefgrobep Alfa Phenprocoumon Lu Ag09222 Deutivacaftor DAPIGLUTIDE Rusfertide Tiapride Azd8630 Timbetasin Acetate Festuca Elatior Pollen Extract Immunostimulants Ceftazidime Cenobamate AMODIAQUINE More therapies…

    Learn about Your Condition

    Stress cardiomyopathy Mucopolysaccharidosis I Acute kidney injury Latent tuberculosis Amyotrophic lateral sclerosis Pre-eclampsia Ejection fraction normal Genital herpes simplex Vomiting Nocturia Hypertonic bladder Hypoaesthesia Adrenoleukodystrophy Osteosarcoma recurrent Chondrocalcinosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Crohn’s disease

  • Study on the Effects of Ozanimod for Children with Moderate to Severe Crohn’s Disease Not Responding to Usual Treatments

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Ozanimod
    Belgium France Germany Hungary Poland Spain

  • Study of Oral Ozanimod as Maintenance Treatment for Adults with Moderate to Severe Crohn’s Disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Ozanimod
    Belgium Bulgaria Croatia Czechia France Germany +8

  • Study on the Long-term Safety of Vedolizumab for Children with Ulcerative Colitis or Crohn’s Disease

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    • Colitis ulcerative
    Investigated Drugs:
    • Vedolizumab
    Hungary Poland

  • Study on Subcutaneous Infliximab for Patients with Ulcerative Colitis, Crohn’s Disease, or Unclassified Inflammatory Bowel Disease

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Inflammatory bowel disease
    • Crohn’s disease
    • Colitis ulcerative
    Investigated Drugs:
    • Infliximab
    Belgium

  • Study on the Long-Term Safety and Efficacy of Oral Ozanimod for Patients with Moderate to Severe Crohn’s Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Ozanimod
    Bulgaria Croatia Czechia France Germany Hungary +9

  • Study on the Effects of TEV-48574 for Adults with Moderate to Severe Ulcerative Colitis or Crohn’s Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Crohn’s disease
    • Colitis ulcerative
    Investigated Drugs:
    • Duvakitug
    Austria Belgium Bulgaria Czechia France Germany +6
Previous Page
1 … 11 12 13 14 15 16
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!